Pavlo Gilchuk

Displaying 1 - 3 of 3

Monoclonal antibody “cocktail” blocks COVID-19 variants: study

Monoclonal antibody “cocktail” blocks COVID-19 variants: study

Related Categories: 
COVID-19 Dolly Parton COVID-19 Research Fund James Crowe Jr. monoclonal antibodies Nature Medicine Naveen Suryadevara NIH funding Pavlo Gilchuk Research Robert Carnahan Seth Zost Vanderbilt Vaccine Center Washington University School of Medicine

Antibody mixture may help block Ebola virus infection

Antibody mixture may help block Ebola virus infection

Related Categories: 
antibody therapies ebola immunity James Crowe Jr. Pavlo Gilchuk Research Vanderbilt Vaccine Center

Vaccine Center team finds potent antibodies against three Ebola viruses

Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans.

Related Categories: 
Department of Pediatrics ebola immunity James Crowe Jr. monoclonal antibodies NIH pathology microbiology and immunology Pavlo Gilchuk Vanderbilt Vaccine Center